Scarica l'app Stockscreener
17.41
2.90%
-0.52
Dopo l'orario di chiusura:
17.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IMVT Giù?
Forum
Previsione
Precedente Chiudi:
$17.93
Aprire:
$18.07
Volume 24 ore:
1.96M
Relative Volume:
1.30
Capitalizzazione di mercato:
$3.03B
Reddito:
-
Utile/perdita netta:
$-382.71M
Rapporto P/E:
-6.645
EPS:
-2.62
Flusso di cassa netto:
$-325.64M
1 W Prestazione:
-0.40%
1M Prestazione:
+13.87%
6M Prestazione:
+17.32%
1 anno Prestazione:
-40.32%
Intervallo 1D:
$17.11
$18.38
Intervallo di 1 settimana:
$16.59
$18.38
Portata 52W:
$12.72
$32.10
Immunovant Inc Stock (IMVT) Company Profile
Nome
Immunovant Inc
Settore
Industria
Telefono
917-580-3099
Indirizzo
320 WEST 37TH STREET, NEW YORK, NY
Confronta IMVT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
17.41 | 3.05B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-03-03 | Iniziato | Jefferies | Hold |
| 2025-01-03 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-10-09 | Reiterato | Oppenheimer | Outperform |
| 2024-03-28 | Iniziato | Oppenheimer | Outperform |
| 2024-03-13 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | JP Morgan | Overweight |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-10-13 | Aggiornamento | UBS | Neutral → Buy |
| 2023-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | Iniziato | BofA Securities | Buy |
| 2023-04-25 | Iniziato | Citigroup | Buy |
| 2023-03-31 | Iniziato | Piper Sandler | Overweight |
| 2023-03-30 | Iniziato | Stifel | Buy |
| 2023-02-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-01-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | Downgrade | UBS | Buy → Neutral |
| 2021-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2021-08-03 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-06-01 | Downgrade | Stifel | Buy → Hold |
| 2020-10-28 | Iniziato | UBS | Buy |
| 2020-10-12 | Iniziato | Guggenheim | Buy |
| 2020-10-08 | Iniziato | Stifel | Buy |
| 2020-10-02 | Iniziato | Credit Suisse | Outperform |
| 2020-08-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-25 | Iniziato | Raymond James | Outperform |
| 2020-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-02-24 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Immunovant Inc Borsa (IMVT) Ultime notizie
Why Immunovant Inc. stock is popular among millennials2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
Visualizing Immunovant Inc. stock with heatmaps2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
Reversal indicators forming on Immunovant Inc. stockGold Moves & High Yield Equity Trading Tips - newser.com
Key resistance and support levels for Immunovant Inc.Quarterly Trade Report & Community Consensus Trade Alerts - newser.com
Will Immunovant Inc. stock outperform value stocksJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - newser.com
Trend analysis for Immunovant Inc. this weekRate Cut & High Conviction Buy Zone Alerts - newser.com
Truist Securities initiates Immunovant stock with Hold rating, $16 target - Investing.com
Statistical indicators supporting Immunovant Inc.’s strengthJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com
How analysts rate Immunovant Inc. stock todayJuly 2025 Review & Free Technical Pattern Based Buy Signals - newser.com
Analyzing drawdowns of Immunovant Inc. with statistical toolsPortfolio Growth Summary & Stock Timing and Entry Methods - newser.com
How hedge fund analytics apply to Immunovant Inc. stockDollar Strength & Short-Term Trading Alerts - newser.com
Immunovant (NASDAQ:IMVT) Insider Michael Geffner Sells 1,272 Shares - MarketBeat
Immunovant (NASDAQ:IMVT) Shares Up 7.2%Here's What Happened - MarketBeat
Immunovant’s chief technology officer sells $25,835 in stock By Investing.com - Investing.com South Africa
Will breakout in Immunovant Inc. lead to full recovery2025 Technical Patterns & AI Driven Price Predictions - newser.com
Immunovant Inc. stock momentum explainedMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
Smart tools for monitoring Immunovant Inc.’s price action2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN
Published on: 2025-10-09 06:28:21 - newser.com
Using Ichimoku Cloud for Immunovant Inc. technicalsMarket Activity Summary & Real-Time Volume Analysis Alerts - newser.com
Is Immunovant Inc. forming a bottoming baseJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Immunovant Inc. stock remains undervalued2025 Bull vs Bear & Stock Market Timing Techniques - newser.com
Platinum Investment Management Ltd. Grows Position in Immunovant, Inc. $IMVT - MarketBeat
Where is Immunovant (IMVT) Heading According to Analysts? - MSN
Immunovant (NASDAQ:IMVT) Given New $33.00 Price Target at JPMorgan Chase & Co. - MarketBeat
12 Best Strong Buy Stocks to Invest in According to Wall Street - Insider Monkey
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue? - MSN
Is Asahi India Glass Limited One of the Top Picks for Growth Investors in YEARPrice Action Analysis & Free Phenomenal Trading Returns - earlytimes.in
What analysts say about Immunovant Inc stockFinancial Sector Performance & Free Proven Portfolio Growth Strategies - earlytimes.in
Banque Pictet & Cie SA Has $2.02 Million Stock Holdings in Immunovant, Inc. $IMVT - MarketBeat
Insider Sale: President & Immunovant CEO of $ROIV Sells 683,818 Shares - Quiver Quantitative
Immunovant Inc Azioni (IMVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immunovant Inc Azioni (IMVT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stout Jay S | Chief Technology Officer |
Oct 08 '25 |
Sale |
16.30 |
1,585 |
25,836 |
203,334 |
| Stout Jay S | Chief Technology Officer |
Jul 23 '25 |
Sale |
18.15 |
2,805 |
50,911 |
204,919 |
| Geffner Michael | Chief Medical Officer |
Jul 23 '25 |
Sale |
18.15 |
2,385 |
43,288 |
221,825 |
| Geffner Michael | Chief Medical Officer |
Jul 09 '25 |
Sale |
17.24 |
1,160 |
19,998 |
224,210 |
| Stout Jay S | Chief Technology Officer |
Jul 09 '25 |
Sale |
17.24 |
1,519 |
26,188 |
207,724 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):